From: A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
Pt
Grade min
Grade max
pt 1
0
2
pt 2
pt 3
1
4
pt 4
pt 5
pt 6
pt 7
pt 8
pt 9
pt 10
3
pt 11
pt 12
pt 13
pt 14
pt 15
pt 16
pt 17
pt 18
pt 19
pt 20